A fine line: US lays out restrictive funding path for H5N1, other risky research
This article was originally published in Scrip
Executive Summary
Officials from the National Institutes of Health (NIH) and the White House Office of Science and Technology Policy (OSTP) on 21 February laid out the conditions under which the federal government would fund scientific research involving especially dangerous pathogens and toxins, such as the highly pathogenic avian influenza (HPAI) H5N1 virus.